Strain differences in systematic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (23) , 2359-2363
- https://doi.org/10.1016/0024-3205(88)90189-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Blood‐Brain Barrier Monoamine Oxidase: Enzyme Characterization in Cerebral Microvessels and Other Tissues from Six Mammalian Species, Including HumanJournal of Neurochemistry, 1987
- Difference in monoamine oxidase B activity between C57 black and albino NMRI mouse strains may explain differential effects of the neurotoxin MPTPNeuroscience Letters, 1987
- Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridium (MPP+) and not blocked by deprenylLife Sciences, 1986
- Monoamine neurotransmitters in diffuse reversible forebrain ischemia and early recirculationNeurology, 1986
- MPTPNeurology, 1986
- Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sourcesEuropean Journal of Pharmacology, 1985
- Specific Ouabain Binding to Brain Microvessels and Choroid PlexusJournal of Cerebral Blood Flow & Metabolism, 1985
- IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effectsLife Sciences, 1985
- MPTP and parkinson's diseaseTrends in Neurosciences, 1985